Evidence map›Paper›PMID 39541263›Full record

ArticleThe oncologist2025

"Treatable not curable": trade-offs in the use of treatment-oriented language with patients who have incurable cancer.

Jason N Batten, Kristin M Kennedy, Bonnie O Wong, Stephanie A Kraft, William Hanks, David Magnus, Lidia Schapira

Abstract read
In one paragraph

Article in The oncologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jason N BattenDepartment of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, CA 90095, United States.
Kristin M KennedyStanford University School of Medicine, Stanford, CA 94305, United States.ORCID 0000-0001-7082-8688
Bonnie O WongDepartment of Surgery, Brigham and Women's Hospital, Boston, MA 02115, United States.
Stephanie A KraftDepartment of Bioethics and Decision Sciences, Geisinger College of Health Sciences, Danville, PA 17822, United States.
William HanksDepartment of Anthropology, University of California, Berkeley, CA 94720, United States.
David MagnusStanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94305, United States.
Lidia SchapiraStanford Cancer Institute, Stanford University, Stanford, CA 94305, United States.

Funding

Stanford Medical Scholars Research Fellowship Program #11635University of California Berkeley Social Science Matrix
6 · The paper itself

Abstract

Treatment-oriented language is used by physicians to convey to patients that treatment is available for their cancer (eg, "our usual treatment for this is…," "we can treat this," "your cancer is still treatable"). For patients who have incurable cancer, especially for patients with a poor prognosis or who are at the end of life, it is important to understand how physicians conceptualize and use this "everyday" clinical language. We conducted a qualitative interview study with a multidisciplinary group of physicians (n = 30) who may care for patients with cancer at different points in their clinical course, from diagnosis to end of life. Physicians report a wide range of reasons for using treatment-oriented language in conversations with patients who have incurable cancer. However, physicians also reported concerns that this language can be ambiguous, can convey unintended positive prognostic information, and can shift attention away from important matters such as the non-curative nature of treatment or the inevitability of death. On the basis of these concerns, physicians should (1) consider whether their aims in using treatment-oriented language can be better achieved using other evidence-based communication strategies, and (2) recognize and proactively mitigate potential adverse effects of treatment-oriented language, which may manifest much later in the patient's clinical course.

Indexed as

NeoplasmsPhysician-Patient RelationsCommunicationFemaleHumansLanguageMaleMiddle AgedPrognosisTerminal Carecancerend-of-life carepatient–provider communicationprognosistreatability statements

Identifiers

PMID39541263
PMCPMC11954508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.